Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).

Adolescents Adults CGM Children Continuous glucose monitoring Exercise Physical activity Position statement Type 1 diabetes

Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 14 10 2020
medline: 3 11 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and duration of the type of exercise. Understandably, fear of hypoglycaemia is one of the strongest barriers to incorporating exercise into daily life. Risk of hypoglycaemia during and after exercise can be lowered when insulin-dose adjustments are made and/or additional carbohydrates are consumed. Glycaemic management during exercise has been made easier with continuous glucose monitoring (CGM) and intermittently scanned continuous glucose monitoring (isCGM) systems; however, because of the complexity of CGM and isCGM systems, both individuals with type 1 diabetes and their healthcare professionals may struggle with the interpretation of given information to maximise the technological potential for effective use around exercise (i.e. before, during and after). This position statement highlights the recent advancements in CGM and isCGM technology, with a focus on the evidence base for their efficacy to sense glucose around exercise and adaptations in the use of these emerging tools, and updates the guidance for exercise in adults, children and adolescents with type 1 diabetes. Graphical abstract.

Identifiants

pubmed: 33047169
doi: 10.1007/s00125-020-05263-9
pii: 10.1007/s00125-020-05263-9
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2501-2520

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Othmar Moser (O)

Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria. Othmar.moser@medunigraz.at.
Division of Exercise Physiology and Metabolism, Department of Sport Science, University of Bayreuth, Bayreuth, Germany. Othmar.moser@medunigraz.at.

Michael C Riddell (MC)

School of Kinesiology and Health Science, York University, Toronto, ON, Canada.

Max L Eckstein (ML)

Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.

Peter Adolfsson (P)

Department of Pediatrics, The Hospital of Halland, Kungsbacka, Sweden.
Sahlgrenska Academy at University of Gothenburg, Institution of Clinical Sciences, Gothenburg, Sweden.

Rémi Rabasa-Lhoret (R)

Institut de Recherches Cliniques de Montréal, Montréal, QC, Canada.
Endocrinology Division Centre Hospitalier Universitaire de Montréal, Montréal, QC, Canada.
Nutrition Department, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Montreal Diabetes Research Centre, Montréal, QC, Canada.

Louisa van den Boom (L)

Division of Pediatric Diabetology, DRK Children's Hospital, Siegen, Germany.

Pieter Gillard (P)

Department of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Kirsten Nørgaard (K)

Steno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.

Nick S Oliver (NS)

Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, London, UK.

Dessi P Zaharieva (DP)

Department of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA.

Tadej Battelino (T)

Department of Paediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Carine de Beaufort (C)

Department of Pediatric Diabetes and Endocrinology, Centre Hospitalier Luxembourg, Luxembourg, Luxembourg.
Department of Pediatrics, Free University Brussels (VUB), Brussels, Belgium.

Richard M Bergenstal (RM)

International Diabetes Center, Minneapolis, MN, USA.

Bruce Buckingham (B)

Department of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA.

Eda Cengiz (E)

Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
Bahçeşehir Üniversitesi, Istanbul, Turkey.

Asma Deeb (A)

Paediatric Endocrinology Division, Shaikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.

Simon Heller (S)

Department of Oncology & Metabolism, The Medical School, University of Sheffield, Sheffield, UK.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Lalantha Leelarathna (L)

Manchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Chantal Mathieu (C)

Department of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Christoph Stettler (C)

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

Martin Tauschmann (M)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Hood Thabit (H)

Manchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Emma G Wilmot (EG)

Diabetes Department, Royal Derby Hospital, University Hospitals of Derby and Burton NHSFT, Derby, UK.
Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, UK.

Harald Sourij (H)

Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.

Carmel E Smart (CE)

School of Health Sciences, University of Newcastle, Callaghan, NSW, Australia.
Department of Paediatric Diabetes and Endocrinology, John Hunter Children's Hospital, Newcastle, NSW, Australia.

Peter G Jacobs (PG)

Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.

Richard M Bracken (RM)

Applied Sport, Technology, Exercise and Medicine Research Centre (A-STEM), College of Engineering, Swansea University, Swansea, UK.

Julia K Mader (JK)

Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH